Stock SYRE SPYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-14 EDT 		5-day change 1st Jan Change
39.29 USD +6.19% Intraday chart for Spyre Therapeutics, Inc. +14.75% +82.57%
05-13 Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating MT
05-09 Spyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SPYRE THERAPEUTICS, INC.
Bio Therapeutic Drugs
+6.19%+14.75%+82.57%+926.52%-76.92% 1.49B
Bullish
Bullish
Bullish
  1. Stock Market
  2. Equities
  3. SYRE Stock
  4. Charts Spyre Therapeutics, Inc.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW